Fluidigm Set to Expand C1 Application Menu to Include Single-Cell DNA Sequencing | GenomeWeb

Fluidigm continues to expand the menu of applications that can be run on single cells prepared for analysis on its C1 Single-Cell AutoPrep System.

CEO Gajus Worthington told investors during the firm's third quarter earnings call last week that the company will soon introduce single-cell whole-genome amplification for the C1, enabling customers to perform targeted DNA sequencing of up to 480 regions.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.